Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS302 in cataract extraction with lens replacement
NCT00721695Phase 2Completed
- Sponsor
- Omeros Corporation
- Start
- May 2008
- Primary completion
- Feb 2009
- Countries
- 1
01
Overview
A Phase 2 trial of phenylephrine + ketorolac in cataract, sponsored by Omeros Corporation. Started May 2008; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00721695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721695.